Lotus Eye Hospital and Institute Limited (LOTUSEYE) - Total Assets

Latest as of September 2025: Rs715.15 Million INR ≈ $7.73 Million USD

Based on the latest financial reports, Lotus Eye Hospital and Institute Limited (LOTUSEYE) holds total assets worth Rs715.15 Million INR (≈ $7.73 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Lotus Eye Hospital and Institute Limited net assets for net asset value and shareholders' equity analysis.

Lotus Eye Hospital and Institute Limited - Total Assets Trend (2007–2025)

This chart illustrates how Lotus Eye Hospital and Institute Limited's total assets have evolved over time, based on quarterly financial data.

Lotus Eye Hospital and Institute Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Lotus Eye Hospital and Institute Limited's total assets of Rs715.15 Million consist of 16.6% current assets and 83.4% non-current assets.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs41.51 Million 2.9%
Accounts Receivable Rs13.23 Million 1.9%
Inventory Rs38.30 Million 5.5%
Property, Plant & Equipment Rs539.42 Million 77.5%
Intangible Assets Rs1.30 Million 0.2%
Goodwill Rs0.00 0.0%

Asset Composition Trend (2007–2025)

This chart illustrates how Lotus Eye Hospital and Institute Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Lotus Eye Hospital and Institute Limited stock valuation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Lotus Eye Hospital and Institute Limited's current assets represent 16.6% of total assets in 2025, a decrease from 24.7% in 2007.
  • Cash Position: Cash and equivalents constituted 2.9% of total assets in 2025, up from 0.0% in 2007.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2007.
  • Asset Diversification: The largest asset category is property, plant & equipment at 77.5% of total assets.

Lotus Eye Hospital and Institute Limited Competitors by Total Assets

Key competitors of Lotus Eye Hospital and Institute Limited based on total assets are shown below.

Company Country Total Assets
Sanbo Hospital Management Group Ltd. A
SHE:301293
China CN¥3.72 Billion
WELL Health Technologies Corp
TO:WELL
Canada CA$2.02 Billion
Hospital Mater Dei S.A
SA:MATD3
Brazil R$4.40 Billion
MEDICLIN Aktiengesellschaft
XETRA:MED
Germany €879.69 Million
Ramsay Health Care Ltd
AU:RHC
Australia AU$22.48 Billion
Regis Healthcare Ltd
AU:REG
Australia AU$2.11 Billion
Oceania Healthcare Ltd
AU:OCA
Australia AU$3.01 Billion
Pacific Smiles Group Ltd
AU:PSQ
Australia AU$163.53 Million

Lotus Eye Hospital and Institute Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.40 1.52 1.85
Quick Ratio 0.90 1.02 1.55
Cash Ratio 0.44 0.59 0.00
Working Capital Rs29.89 Million Rs40.27 Million Rs50.40 Million

Lotus Eye Hospital and Institute Limited - Advanced Valuation Insights

This section examines the relationship between Lotus Eye Hospital and Institute Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 4.21
Latest Market Cap to Assets Ratio 0.04
Asset Growth Rate (YoY) 4.4%
Total Assets Rs695.74 Million
Market Capitalization $26.73 Million USD

Valuation Analysis

Below Book Valuation: The market values Lotus Eye Hospital and Institute Limited's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Lotus Eye Hospital and Institute Limited's assets grew by 4.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Lotus Eye Hospital and Institute Limited (2007–2025)

The table below shows the annual total assets of Lotus Eye Hospital and Institute Limited from 2007 to 2025.

Year Total Assets Change
2025-03-31 Rs695.74 Million
≈ $7.52 Million
+4.42%
2024-03-31 Rs666.27 Million
≈ $7.21 Million
+5.44%
2023-03-31 Rs631.88 Million
≈ $6.83 Million
+2.58%
2022-03-31 Rs615.97 Million
≈ $6.66 Million
+4.00%
2021-03-31 Rs592.29 Million
≈ $6.41 Million
+1.93%
2020-03-31 Rs581.06 Million
≈ $6.28 Million
+2.57%
2019-03-31 Rs566.50 Million
≈ $6.13 Million
-2.68%
2018-03-31 Rs582.12 Million
≈ $6.30 Million
+5.96%
2017-03-31 Rs549.37 Million
≈ $5.94 Million
+0.20%
2016-03-31 Rs548.29 Million
≈ $5.93 Million
-2.81%
2015-03-31 Rs564.15 Million
≈ $6.10 Million
-3.65%
2014-03-31 Rs585.54 Million
≈ $6.33 Million
+2.91%
2013-03-31 Rs568.96 Million
≈ $6.15 Million
+1.51%
2012-03-31 Rs560.49 Million
≈ $6.06 Million
-10.48%
2011-03-31 Rs626.13 Million
≈ $6.77 Million
+10.57%
2010-03-31 Rs566.27 Million
≈ $6.12 Million
-8.79%
2009-03-31 Rs620.87 Million
≈ $6.71 Million
+123.31%
2008-03-31 Rs278.03 Million
≈ $3.01 Million
+17.04%
2007-03-31 Rs237.54 Million
≈ $2.57 Million
--

About Lotus Eye Hospital and Institute Limited

NSE:LOTUSEYE India Medical Care Facilities
Market Cap
$26.73 Million
Rs2.47 Billion INR
Market Cap Rank
#24089 Global
#1334 in India
Share Price
Rs118.87
Change (1 day)
-2.18%
52-Week Range
Rs70.02 - Rs141.38
All Time High
Rs141.38
About

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor las… Read more